1. Diversification of TAM receptor tyrosine kinase function
   Anna Zagórska et al, 2014, Nature Immunology CrossRef
2. Population-based cohort study on the risk of pneumonia in patients with non-traumatic intracranial haemorrhage who use proton pump inhibitors
   Sai-Wai Ho et al, 2014, BMJ Open CrossRef
3. Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?
   Ian Dransfield et al, 2016, Apoptosis in Cancer Pathogenesis and Anti-cancer Therapy CrossRef
4. Potential diagnostic and prognostic of efferocytosis-related unwanted soluble receptors/ligands as new non-invasive biomarkers in disorders: a review
   Amir Tajbakhsh et al, 2022, Molecular Biology Reports CrossRef
5. Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma
   Aleksander M. Grabiec et al, 2017, Journal of Allergy and Clinical Immunology CrossRef
6. Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study
   Ulf Schött et al, 2021, Nutrients CrossRef
7. Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
   Erin D Lew et al, 2014, eLife CrossRef
8. Evaluation of Gas6 and sAxl levels during attacks and attack-free periods of familial Mediterranean fever
   Gokhan Cakirca et al, 2018, Turkish Journal of Biochemistry CrossRef
9. The TAM Receptor Family
   Greg Lemke, 2015, Receptor Tyrosine Kinases: Family and Subfamilies CrossRef
10. Accurate Determination of Soluble Axl by Enzyme-Linked Immunosorbent Assay
    Mirko Dengler et al, 2016, ASSAY and Drug Development Technologies CrossRef
11. Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH
    Sturla Magnus Grøndal et al, 2024, Frontiers in Immunology CrossRef
12. A literature review of severity scores for adults with influenza or community-acquired pneumonia – implications for influenza vaccines and therapeutics
    Katherine Adams et al, 2024, Human Vaccines & Immunotherapeutics CrossRef